A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy
β Scribed by Daniel M. Green; Gary V. Burton; Edwin B. Cox; Dean Hanson; Joseph Moore; James R. Oleson
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 126 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du Β¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the
## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat